Dual Control of Low-Density Lipoprotein Cholesterol Levels by ANGPTL3 and ANGPTL8.
A8 acts in concert with A3 to differentially modulate lipoprotein lipase- and endothelial lipase-mediated lipolysis, which antagonizes hepatic clearance of newly secreted atherogenic ApoB-containing lipoproteins.